BRC Trials Office: A central contact point for clinical trials in psychosis
Can we find new treatments for psychosis?
The development of new treatments is of major importance. The NIHR Biomedical Research Centre for Mental Health and Dementia Unit (BRC/U) at South London and Maudsley NHS Foundation Trust (SLaM) and the Institute of Psychiatry (IoP), King’s College London is at the forefront of research into new anti-psychotic medications. But we need increased patient participation for studies and trials.
Treatments for psychosis and schizophrenia have been developed since the late 1950s. These medications help reduce delusions and hallucinations. For some, these medications are very effective but for others, side effects can impact heavily on a person’s day-to-day activities.
Find out about the trials available.
BRC Trials Office
Despite our long history in research, patients and their carers might be unaware that numerous ongoing research trials are available and key-workers may not know who to contact. Our office is here to make the connection between patients and key-workers with researchers. We co-ordinate a range of trials in psychosis and schizophrenia which can be both pharmacological and psychosocial.
We welcome contact from SLaM staff and patients to discuss the current studies in more detail. Ideally our patients will have a choice from a number of trials. We are happy to talk about what is being asked of patients, what they will get from taking part and how things can proceed.
We are located in the Psychosis Studies Department at the IoP. You contact us by:
Phone: 0207 848 0057
BRC Trials Office Team: Alice Egerton, Paul Morrison, Alex Kralj